Medpace (NASDAQ:MEDP) Lifted to Buy at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday, MarketBeat.com reports. They currently have $450.00 price objective on the stock, up from their prior price objective of $340.00. MEDP has been the subject of several other reports. […]

Related Keywords

United States ,America ,Susane Burwig ,Robertw Baird , ,Arcadia Investment Management Corp ,Securities Exchange Commission ,Coldstream Capital Management Inc ,Medpace Investors Llc ,Medpace Holdings Inc ,Deutsche Bank Aktiengesellschaft ,Schulhoff Co ,Miller Howard Investments Inc ,Jefferies Financial Group ,Free Report ,Moderate Buy ,Get Free Report ,Medpace Investors ,Exchange Commission ,Investment Management Corp ,Howard Investments ,Capital Management ,North America ,Medpace Daily ,Medpace ,Nasdaq Medp ,Medp ,Medical ,Upgrade ,Jefferies Financial Group Inc ,